Saleh, Shadi http://orcid.org/0000-0001-8689-4030
Dabbous, Omar
Sullivan, Sean D.
Ankleshwaria, Dipen
Trombini, Daiane
Toumi, Mondher
Diaa, Mahmoud
Patel, Anish
Kazazoglu Taylor, Burcu
Tunis, Sean
Funding for this research was provided by:
Novartis Gene Therapies, Inc.
Article History
Received: 5 May 2023
Revised: 19 September 2023
Accepted: 4 October 2023
First Online: 30 October 2023
Competing interests
: OD, DA, DT, MD, AP, and BKT are employees of Novartis Gene Therapies, Inc., and own stock/other equities. SS and MT have received consulting fees from Novartis Gene Therapies, Inc., for this research. SDS has received research grants and consulting fees from Novartis Gene Therapies, Inc., and served as consultant/on an advisory board for Bayer US. ST has received honoraria from Novartis Gene Therapies, Inc. He has also received payment for participation on a BioMarin advisory board and participated in a scientific advisory board meeting for UCB Pharma.